These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31339775)

  • 1. Human Th17 cells produce a soluble mediator that increases podocyte motility via signaling pathways that mimic PAR-1 activation.
    May CJ; Welsh GI; Chesor M; Lait PJ; Schewitz-Bowers LP; Lee RWJ; Saleem MA
    Am J Physiol Renal Physiol; 2019 Oct; 317(4):F913-F921. PubMed ID: 31339775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the protein kinase MK-2 protects podocytes from nephrotic syndrome-related injury.
    Pengal R; Guess AJ; Agrawal S; Manley J; Ransom RF; Mourey RJ; Benndorf R; Smoyer WE
    Am J Physiol Renal Physiol; 2011 Sep; 301(3):F509-19. PubMed ID: 21613416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating extracellular vesicles of patients with steroid-sensitive nephrotic syndrome have higher RAC1 and induce recapitulation of nephrotic syndrome phenotype in podocytes.
    Eroglu FK; Yazar V; Guler U; Yıldırım M; Yildirim T; Gungor T; Celikkaya E; Karakaya D; Turay N; Ciftci Dede E; Korkusuz P; Salih B; Bulbul M; Gursel I
    Am J Physiol Renal Physiol; 2021 Nov; 321(5):F659-F673. PubMed ID: 34569252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events.
    May CJ; Chesor M; Hunter SE; Hayes B; Barr R; Roberts T; Barrington FA; Farmer L; Ni L; Jackson M; Snethen H; Tavakolidakhrabadi N; Goldstone M; Gilbert R; Beesley M; Lennon R; Foster R; Coward R; Welsh GI; Saleem MA
    Kidney Int; 2023 Aug; 104(2):265-278. PubMed ID: 36940798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of TGF-β-induced non-Smad signaling pathways during Th17 differentiation.
    Hasan M; Neumann B; Haupeltshofer S; Stahlke S; Fantini MC; Angstwurm K; Bogdahn U; Kleiter I
    Immunol Cell Biol; 2015 Aug; 93(7):662-72. PubMed ID: 25823994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Th17/IL-17 in the pathogenesis of primary nephrotic syndrome in children.
    Wang L; Li Q; Wang L; Li C; Yang H; Wang X; Tao H
    Kidney Blood Press Res; 2013; 37(4-5):332-45. PubMed ID: 24247026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
    Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
    Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17A participates in podocyte injury by inducing IL-1β secretion through ROS-NLRP3 inflammasome-caspase-1 pathway.
    Yan J; Li Y; Yang H; Zhang L; Yang B; Wang M; Li Q
    Scand J Immunol; 2018 Apr; 87(4):e12645. PubMed ID: 29446486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the IL-2 Receptor in Podocytes: A Potential Mechanism for Podocyte Injury in Idiopathic Nephrotic Syndrome?
    Zea AH; Stewart T; Ascani J; Tate DJ; Finkel-Jimenez B; Wilk A; Reiss K; Smoyer WE; Aviles DH
    PLoS One; 2016; 11(7):e0157907. PubMed ID: 27389192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells.
    Zijlstra GJ; Ten Hacken NH; Hoffmann RF; van Oosterhout AJ; Heijink IH
    Eur Respir J; 2012 Feb; 39(2):439-45. PubMed ID: 21828034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Th17-related genes in PHA/IL-2-activated human T cells by Fas signaling via caspase-1- and Stat3-dependent pathway.
    Su CC; Lin HC; Lin YP; Shan YS; Yang BC
    Cell Immunol; 2013 Feb; 281(2):101-10. PubMed ID: 23590971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell MST1 inhibits Th17 differentiation.
    Li C; Bi Y; Li Y; Yang H; Yu Q; Wang J; Wang Y; Su H; Jia A; Hu Y; Han L; Zhang J; Li S; Tao W; Liu G
    Nat Commun; 2017 Feb; 8():14275. PubMed ID: 28145433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood nephrotic syndrome--current and future therapies.
    Greenbaum LA; Benndorf R; Smoyer WE
    Nat Rev Nephrol; 2012 Jun; 8(8):445-58. PubMed ID: 22688744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of steroids on the injured podocytes in nephrotic syndrome.
    Hosseiniyan Khatibi SM; Ardalan M; Abediazar S; Zununi Vahed S
    J Steroid Biochem Mol Biol; 2020 Feb; 196():105490. PubMed ID: 31586640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of IL-23 p19 expression in human periodontal ligament fibroblasts by IL-1β via concurrent activation of the NF-κB and MAPKs/AP-1 pathways.
    Zhu L; Wu Y; Wei H; Yang S; Zhan N; Xing X; Peng B
    Cytokine; 2012 Oct; 60(1):171-8. PubMed ID: 22688014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFβ1-mediated PI3K/Akt and p38 MAP kinase dependent alternative splicing of fibronectin extra domain A in human podocyte culture.
    Madne TH; Dockrell MEC
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):127-135. PubMed ID: 29729706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
    Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
    Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
    Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
    Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta.
    Iyoda M; Shibata T; Kawaguchi M; Hizawa N; Yamaoka T; Kokubu F; Akizawa T
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F779-87. PubMed ID: 20042461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.